Expression of Human Immunodeficiency Virus Type 1 Tat Proteins in Escherichia coli and Application to Study Tat Functions

Journal of Biochemistry and Molecular Biology

Volumn 33, Issue 4, 2000, Pages 337-343

  Park, Jinseu ^a   Lee, Hangyu ^a   Lee, Yoon ^a   Kang, Young Hee ^a   Rhim, Hyangshuk ^b   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Expression; HIV 1; Purification; Tat; Transactivation

Indexed keywords

EID: 0034422104     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Armengaud, J., de Nuova Perez, L., Lemay, P. and Masson, J. M. (1991) Production of a full length Tat protein in E. coli and its purification. FEBS Lett. 282, 157-160.
2. Arya, S. K., Guo, C., Josephs, S. F. and Wong-Staal, F. (1985) Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229, 69-73.
3. Choi, E. Y., Jang, S. H., Kim, I., Park, S. Y. and Choi, S. Y. (1993) Production and characterization of monoclonal antibodies to bovine brain GABA transaminase. Mol. Cells 3, 451-455.
4. Cullen, B. R. (1986) trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46, 973-982.
5. Dhawan, S., Puri, R. K., Kumar, A., Duplan, H., Masson, J. M. and Aggarwal, B. B. (1997) Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90, 1535-1544.
6. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P. and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
7. Fawell S., Seery J., Daikh Y., Moore C., Chen L. L., Pepinsky B. and Barsoum J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91, 664-668.
8. Fenrick, R., Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. and Cullen, B. R. (1989) Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. J. Virol. 63, 5006-5012.
9. Frankel, A. D. and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
10. Frankel, A. D., Bredt, D. S. and Pabo, C. O. (1988) Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240, 70-73.
11. Hauber, J., Malim, M. I. I. and Cullen, B. R. (1989) Mutational analysis of the conserved basic domain of human immunodeficiency virus Tat protein. J. Virol. 63, 1181-1187.
12. Jaffe, E. A., Nachman, R. L., Becker, C. G. and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
13. Kim, D.-J., Oh, Y.-T., Lee, S. K. and Shin, C.-G. (1999) Biochemical properties of second site mutation of human immunodeficiency virus integrase. J. Biochem. Mol. Biol. 32, 599-604.
14. Kirsch, T., Boehm, M., Schuckert, O., Metzger, A. U., Willbold, D., Frank, R. W. and Rosch, P. (1996) Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein. Protein Expr. Purif. 8, 75-84.
15. Mann, D. A. and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739.
16. Morrow, C. D, Park, J. and Wakefield, J. K. (1994) Viral gene products and replication of the human immunodeficiency type 1 virus. Am. J. Physiol. 266, C1135-C1156.
17. Muesing, M. A., Smith, D. H. and Capon, D. J. (1987) Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48, 691-701.
18. Orsini, M. J., Garcia-Martinez, L. F., Mavankal, G., Gaynor, R. B. and Debouck, C. M. (1996) Purification and functional characterization of wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli. Protein Expr. Purif. 8, 238-246.
19. Rappaport, J., Lee, S.-J., Khalili, K. and Wong-Staal, F. (1989) The acidic amino-terminal region of HIV-1 Tat protein constitutes an essential activating domain. New Biol. 1, 101-110.
20. Rhim, H., Echetebu, C. O., Herrmann, C. H. and Rice, A. P. (1994) Wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli as fusions with glutathione S-transferase. J. Acquired Immune Deficience Syndrome 7, 1116-1121.
21. Rice, A. P. and Carlotti, F. (1990) Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J. Virol. 64, 1864-1868.
22. Rosen, C. A. (1992) HIV regulatory proteins: potential targets for therapeutic intervention. AIDS Res. Hum. Retroviruses. 8, 175-181.
23. Rosen, C. A., Sodroski, J. G. and Haseltine, W. A. (1985) The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41, 813-823.
24. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A. and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus Tat protein. J. Virol. 63, 1-8.
25. Sodroski, J. G., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E. and Haseltine, W. A. (1986) A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (London) 321, 412-417.
26. Tosi, G., Meazza, R., De Lerma Barbaro, A., D'Agostino, A., Mazza, S., Corradin, G., Albini, A., Noonan, D. M., Ferrini, S. and Accolla, R. S. (2000) Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR. Eur. J. Immunol. 30, 1120-1126.
27. Vives, E., Brodin, P. and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
28. Watson, K. and Edwards, R. J. (1999) HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches. Biochem. Pharmacol. 58, 1521-1528.